El Mundo on MSN17h
US approves a new painkiller with less risk of addiction than opioids and equally potentThe suzetrigine, which only acts on pain neurons, is the first innovation in analgesia in the last 20 years. "It stands out ...
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the U.S. Food and Drug Administration (FDA) approved expanded U.S. Prescribing information for IZERVAYâ„¢ ...
The global extended reality market is set for explosive growth with a CAGR of 28.4% during 2025–2031, it was valued at $24.17 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results